Alexza Pharmaceuticals: Here’s What Investors Need to Know Before Earnings

Alexza Pharmaceuticals (NASDAQ:ALXA) will report earnings after markets close on Thursday, May 9th. Alexza Pharmaceuticals, Inc. is a pharmaceutical company focused on the development and commercialization of proprietary products for the treatment of acute and intermittent conditions.

Here is your Cheat Sheet to Alexza Pharmaceuticals Earnings:

Earnings Expectations: Analysts expect earnings of $-0.45 per share on revenues of $1,000.00K.

Analyst Trends:

Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a loss of $0.56 to a loss $0.44. For the current year, the average estimate is a loss of $1.68, which is worse than the estimate ninety days ago.

Earnings Trends:

Here’s how Alexza Pharmaceuticals has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 0.49 9.51 42.88 5.66 4.07
Diluted EPS ($) -18.10 -26.80 -0.27 -5.97 -2.24

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Dec. 31, 2011 Mar. 31, 2012 Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012
Revenue ($) in millions 1.88 1.88 0.73 0.73 0.73
Diluted EPS ($) -1.343 -0.40 -0.58 -0.52 -0.6541

Past Performance:
Alexza Pharmaceuticals has beat analyst estimates 2 times in the past four quarters. This is not consistent enough to get bullish yet.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)